Consolidated statements of changes in redeemable convertible preferred stock and stockholders' equity (deficit) - USD ($) $ in Thousands |
Total |
Initial Public Offering |
Green House Initial Public Offering |
Series A |
Series A
Initial Public Offering
|
Series B-1 |
Series B-1
Initial Public Offering
|
Series B-2 |
Series B-2
Initial Public Offering
|
Common Stock |
Common Stock
Initial Public Offering
|
Common Stock
Green House Initial Public Offering
|
Additional Paid-in Capital |
Additional Paid-in Capital
Initial Public Offering
|
Additional Paid-in Capital
Green House Initial Public Offering
|
Accumulated Deficit |
Accumulated Other Comprehensive Income (Loss) |
| Beginning balance at Dec. 31, 2019 |
$ (64,891)
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
$ 1,421
|
|
|
$ (66,197)
|
$ (115)
|
| Beginning balance, Shares at Dec. 31, 2019 |
10,819,843
|
|
|
|
|
8,344,034
|
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2019 |
$ 100,695
|
|
|
|
|
$ 81,384
|
|
|
|
|
|
|
|
|
|
|
|
| Beginning balance, Shares at Dec. 31, 2019 |
|
|
|
|
|
|
|
|
|
3,927,803
|
|
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options |
261
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
261
|
|
|
|
|
| Issuance of common stock upon exercise of stock options, shares |
|
|
|
|
|
|
|
|
|
188,594
|
|
|
|
|
|
|
|
| Vesting of early exercised common stock |
363
|
|
|
|
|
|
|
|
|
|
|
|
363
|
|
|
|
|
| Issuance of Series A redeemable convertible stock upon exercise of Series A warrants |
|
|
|
$ 1,262
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of Series A redeemable convertible stock upon exercise of Series A warrants, shares |
|
|
|
120,702
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of redeemable convertible preferred stock |
|
|
|
|
|
|
|
$ 40,000
|
|
|
|
|
|
|
|
|
|
| Issuance of redeemable convertible preferred stock, shares |
|
|
|
|
|
|
|
3,569,630
|
|
|
|
|
|
|
|
|
|
| Reclassification of Series A warrant and convertible preferred stock liabilities to equity |
|
|
|
$ 620
|
|
|
|
$ 14,560
|
|
|
|
|
|
|
|
|
|
| Reclassification of Series A warrant and convertible preferred stock liabilities to equity, shares |
|
|
|
|
(10,940,545)
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion of redeemable convertible preferred stock to common stock |
|
$ 238,523
|
|
|
$ (102,577)
|
|
$ (81,384)
|
|
$ (54,560)
|
|
$ 3
|
|
|
$ 238,520
|
|
|
|
| Conversion of redeemable convertible preferred stock to common stock, shares |
|
|
|
|
|
|
(8,344,034)
|
|
(3,569,630)
|
|
22,854,209
|
|
|
|
|
|
|
| Issuance of common stock |
|
$ 139,500
|
$ 16,043
|
|
|
|
|
|
|
|
$ 1
|
$ 0
|
|
$ 139,499
|
$ 16,042
|
|
|
| Issuance of common stock, shares |
|
|
|
|
|
|
|
|
|
|
10,000,000
|
1,150,000
|
|
|
|
|
|
| Costs related to the follow-on offering |
(4,116)
|
|
|
|
|
|
|
|
|
|
|
|
(4,116)
|
|
|
|
|
| Stock-based compensation |
2,975
|
|
|
|
|
|
|
|
|
|
|
|
2,975
|
|
|
|
|
| Other comprehensive loss |
(73)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(73)
|
| Net loss |
(108,543)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(108,543)
|
|
| Ending balance at Dec. 31, 2020 |
220,039
|
|
|
|
|
|
|
|
|
$ 4
|
|
|
394,963
|
|
|
(174,740)
|
(188)
|
| Ending balance, Shares at Dec. 31, 2020 |
|
|
|
|
|
|
|
|
|
38,120,606
|
|
|
|
|
|
|
|
| Issuance of common stock upon exercise of stock options |
394
|
|
|
|
|
|
|
|
|
|
|
|
394
|
|
|
|
|
| Issuance of common stock upon exercise of stock options, shares |
|
|
|
|
|
|
|
|
|
124,013
|
|
|
|
|
|
|
|
| Stock Issued During Period, Value, Employee Stock Purchase Plan |
653
|
|
|
|
|
|
|
|
|
|
|
|
653
|
|
|
|
|
| Stock Issued During Period, Shares, Employee Stock Purchase Plans |
|
|
|
|
|
|
|
|
|
45,610
|
|
|
|
|
|
|
|
| Stock-based compensation expense related to employee stock awards |
12,541
|
|
|
|
|
|
|
|
|
|
|
|
12,541
|
|
|
|
|
| Stock-based compensation expense related to employee stock purchases |
795
|
|
|
|
|
|
|
|
|
|
|
|
795
|
|
|
|
|
| Vesting of early exercised common stock |
292
|
|
|
|
|
|
|
|
|
|
|
|
292
|
|
|
|
|
| Issuance of common stock |
78,584
|
|
|
|
|
|
|
|
|
|
|
|
78,584
|
|
|
|
|
| Issuance of common stock, shares |
|
|
|
|
|
|
|
|
|
4,400,000
|
|
|
|
|
|
|
|
| Costs related to the follow-on offering |
(875)
|
|
|
|
|
|
|
|
|
|
|
|
(875)
|
|
|
|
|
| Other comprehensive loss |
640
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
640
|
| Net loss |
(128,332)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(128,332)
|
|
| Ending balance at Dec. 31, 2021 |
$ 184,731
|
|
|
|
|
|
|
|
|
$ 4
|
|
|
$ 487,347
|
|
|
$ (303,072)
|
$ 452
|
| Ending balance, Shares at Dec. 31, 2021 |
|
|
|
|
|
|
|
|
|
42,690,229
|
|
|
|
|
|
|
|